The Role of MicroRNAs in Liver Cancer Progression

Overview

Journal Br J Cancer

Specialty Oncology

Date 2010 Nov 25

PMID 21102580

Citations 108

Authors

S Huang

X He

Affiliations

Soon will be listed here.

Abstract

Primary liver cancer, predominantly consisting of hepatocellular carcinoma (HCC), is one of the most common and aggressive human malignancies worldwide. MicroRNAs (miRNAs) are a class of small non-coding RNAs that regulate gene expression post-transcriptionally. Emerging evidence indicates that miRNAs are often deregulated in HCC, and that some specific miRNAs are associated with the clinicopathological features of HCC. Recent work demonstrates that miRNAs have essential roles in HCC progression and directly contribute to cell proliferation, avoidance of apoptotic cell death, and metastasis of HCC by targeting a large number of critical protein-coding genes. The discovery of the aberrantly expressed miRNAs and their corresponding targets has opened a novel avenue to investigate the molecular mechanism of HCC progression and to develop potential therapeutics against HCC. In this review, we summarise current knowledge about the roles and validated targets of miRNAs in liver cancer progression.

Citing Articles

Characterization of microRNA-223-3p as a novel promoter of cell proliferation and invasion in papillary thyroid carcinoma.

Pan X, Liu J, Zhang Y, Sun C, Li Y, Guo H J Cell Commun Signal. 2024; 19(1):e12057.

PMID: 39712860 PMC: 11658962. DOI: 10.1002/ccs3.12057.

Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis.

Tian Y, Zhang M, Liu L, Wang Z, Liu B, Huang Y Front Immunol. 2024; 15:1400744.

PMID: 38799446 PMC: 11116607. DOI: 10.3389/fimmu.2024.1400744.

HCV and tumor-initiating stem-like cells.

Machida K Front Physiol. 2022; 13:903302.

PMID: 36187761 PMC: 9520593. DOI: 10.3389/fphys.2022.903302.

Low adipocyte hepatocellular carcinoma is associated with aggressive cancer biology and with worse survival.

Mukhopadhyay S, Tokumaru Y, Oshi M, Endo I, Yoshida K, Takabe K Am J Cancer Res. 2022; 12(8):4028-4039.

PMID: 36119828 PMC: 9442007.

Prognostic MicroRNA Panel for HCV-Associated HCC: Integrating Computational Biology and Clinical Validation.

Dabbish A, Abdelzaher H, Abohawya M, Shamma S, Mahmoud Y, Maged A Cancers (Basel). 2022; 14(13).

PMID: 35804809 PMC: 9265118. DOI: 10.3390/cancers14133036.

References

Tsai W, Hsu P, Lai T, Chau G, Lin C, Chen C . MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology. 2009; 49(5):1571-82. DOI: 10.1002/hep.22806. View

Zhang R, Wang L, Yu G, Zhang X, Yao L, Yang A . MicroRNA-122 might be a double-edged sword in hepatocellular carcinoma. Hepatology. 2009; 50(4):1322-3. DOI: 10.1002/hep.23108. View

Zhang X, Liu S, Hu T, Liu S, He Y, Sun S . Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology. 2009; 50(2):490-9. DOI: 10.1002/hep.23008. View

Liu W, Yeh S, Lu C, Yu S, Chen H, Lin C . MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology. 2008; 136(2):683-93. DOI: 10.1053/j.gastro.2008.10.029. View

Yao J, Liang L, Huang S, Ding J, Tan N, Zhao Y . MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology. 2010; 51(3):846-56. DOI: 10.1002/hep.23443. View

Ji J, Zhao L, Budhu A, Forgues M, Jia H, Qin L . Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J Hepatol. 2010; 52(5):690-7. PMC: 2862772. DOI: 10.1016/j.jhep.2009.12.025. View

Gramantieri L, Fornari F, Ferracin M, Veronese A, Sabbioni S, Calin G . MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality. Clin Cancer Res. 2009; 15(16):5073-81. PMC: 3900721. DOI: 10.1158/1078-0432.CCR-09-0092. View

Fornari F, Gramantieri L, Ferracin M, Veronese A, Sabbioni S, Calin G . MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene. 2008; 27(43):5651-61. DOI: 10.1038/onc.2008.178. View

Xu T, Zhu Y, Xiong Y, Ge Y, Yun J, Zhuang S . MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology. 2009; 50(1):113-21. DOI: 10.1002/hep.22919. View

10.

Li Y, Tan W, Neo T, Aung M, Wasser S, Lim S . Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma. Cancer Sci. 2009; 100(7):1234-42. DOI: 10.1111/j.1349-7006.2009.01164.x. View

11.

He L, Hannon G . MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004; 5(7):522-31. DOI: 10.1038/nrg1379. View

12.

Furuta M, Kozaki K, Tanaka S, Arii S, Imoto I, Inazawa J . miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis. 2009; 31(5):766-76. DOI: 10.1093/carcin/bgp250. View

13.

Yang L, Ma Z, Wang D, Zhao W, Chen L, Wang G . MicroRNA-602 regulating tumor suppressive gene RASSF1A is overexpressed in hepatitis B virus-infected liver and hepatocellular carcinoma. Cancer Biol Ther. 2010; 9(10):803-8. DOI: 10.4161/cbt.9.10.11440. View

14.

le Sage C, Nagel R, Egan D, Schrier M, Mesman E, Mangiola A . Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J. 2007; 26(15):3699-708. PMC: 1949005. DOI: 10.1038/sj.emboj.7601790. View

15.

Lin C, Gong H, Tseng H, Wang W, Wu J . miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. Biochem Biophys Res Commun. 2008; 375(3):315-20. DOI: 10.1016/j.bbrc.2008.07.154. View

16.

Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S . MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res. 2009; 69(14):5761-7. DOI: 10.1158/0008-5472.CAN-08-4797. View

17.

Ivanovska I, Ball A, Diaz R, Magnus J, Kibukawa M, Schelter J . MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol. 2008; 28(7):2167-74. PMC: 2268421. DOI: 10.1128/MCB.01977-07. View

18.

Xiong Y, Fang J, Yun J, Yang J, Zhang Y, Jia W . Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Hepatology. 2009; 51(3):836-45. DOI: 10.1002/hep.23380. View

19.

Lan F, Wang H, Chen Y, Chan C, Ng S, Li K . Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16(INK4A). Int J Cancer. 2010; 128(2):319-31. DOI: 10.1002/ijc.25336. View

20.

Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B . miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A. 2009; 107(1):264-9. PMC: 2806773. DOI: 10.1073/pnas.0907904107. View